Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS

Abroad (travel likely)Recruiting

Conditions

Antiphospholipid Syndrome · Arterial Thrombosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Instituto de Investigaciones en Salud Pública, Universidad de Buenos Aires, Buenos Aires, Buenos Aires F.D., Argentina
Contact: Study coordinator (Patricia Casais, MD, PhD) · patricia.casais@odontologia.uba.ar · (11)50324141
Clinica Universitaria Reina Fabiola, Córdoba, Argentina
Contact: Study coordinator (Soledad Molnar, MD) · 0351-4142121
McMaster University, Hamilton, Ontario, Canada
Contact: Study coordinator (Sam Schulman) · schulms@mcmaster.ca · 9059796437

Study leads

Cary Clark
Study Director
International Society on Thrombosis and Haemostasis

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants

Antiphospholipid Syndrome · Thrombosis · Anticoagulants Causing Adverse Effects in Therapeutic Use

Abroad (travel likely)Recruiting

Nancy, France

Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases

Rheumatoid Arthritis (RA) · Juvenile Idiopathic Arthritis (JIA) · Systemic Lupus Erythematosus (SLE)

Abroad (travel likely)RecruitingPHASE4

São Paulo, Brazil · São Paulo, Brazil

Anifrolumab in Adults With Primary Antiphospholipid Syndrome (AnifAPS Trial)

Antiphospholipid Syndrome (APS)

Abroad (travel likely)RecruitingPHASE2

Athens, Greece

Genetic Risk Factors Associated With Antiphospholipid Antibody Syndrome

Antiphospholipid Syndrome

Abroad (travel likely)Recruiting

Durham, United States